20/20 BIOLABS, INC. Shares Authorized
20/20 BIOLABS, INC. (AIDX) had Shares Authorized of 50.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-14
- 2026-06-30: Common Stock, Shares Authorized 50.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 50.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 50.00M shares.
- 2024-12-31: Common Stock, Shares Authorized 50.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 50.00M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 50.00M shares 10-Q · filed 2026-05-20 |
| 2025-12-31 | 50.00M shares 10-Q · filed 2026-08-14 |
| 2024-12-31 | 50.00M shares POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |